Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease

Progress in Lipid Research

Volumn 49, Issue 4, 2010, Pages 316-334

  Gangoiti, Patricia ^a   Camacho, Luz ^b   Arana, Lide ^a   Ouro, Alberto ^a   Granado, Maria H ^a   Brizuela, Leyre ^a   Casas, Josefina ^b   Fabriás, Gemma ^b   Abad, José Luis ^b   Delgado, Antonio ^b,c   Gómez Muñoz, Antonio ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Cell proliferation; Ceramidases; Ceramide kinase; Ceramide 1 phosphate; Ceramides; Inflammation; Migration; Sphingolipids; Sphingomyelinases; Sphingosine 1 phosphate; Sphingosine kinase

Indexed keywords

2 (4 ETHYL 1 PIPERAZINYL) 4 PHENYLQUINOLINE DIMALEATE; 2 (N TETRADECANOYLAMINO) 1 (4' NITROPHENYL) 1,3 PROPANEDIOL; ABC 294640; ACID CERAMIDASE; ACID CERAMIDASE INHIBITOR; ALKALINE CERAMIDASE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; APOPTIN; BML 258; CARRIER PROTEIN; CERAMIDASE INHIBITOR; CERAMIDE; CERAMIDE KINASE; CERAMIDE KINASE INHIBITOR; CERAMIDE TRANSFER PROTEIN; DEXTRO ERYTHRO 2 (N MYRISTOYLAMINO) 1 PHENYL 1 PROPANOL; FLUORESCENT CERAMIDE; LCL 204; LCL 464; NEUTRAL CERAMIDASE; PROTEIN KINASE C; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN SYNTHASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE MONOCLONAL ANTIBODY; SPHINGOSINE KINASE; SPHINGOSINE KINASE INHIBITOR; SYNTHETASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ATHEROGENESIS; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CROHN DISEASE; DEPHOSPHORYLATION; DRUG STRUCTURE; FARBER DISEASE; GENE EXPRESSION; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HYDROLYSIS; INTRACELLULAR TRANSPORT; LIPID METABOLISM; LIPID TRANSPORT; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIVITY; REVIEW;

ANIMALS; CERAMIDASES; CERAMIDES; DISEASE; HUMANS; INFLAMMATION; ISOENZYMES; LYSOPHOSPHOLIPIDS; MACROPHAGES; MOLECULAR STRUCTURE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE;

EID: 77956395451     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2010.02.004     Document Type: Review

References (297)

1. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat Rev Mol Cell Biol 9 2008 139 150
2. N. Bartke, and Y.A. Hannun Bioactive sphingolipids: metabolism and function J Lipid Res 50 Suppl. 2009 S91 S96
3. K. Simons, and D. Toomre Lipid rafts and signal transduction Nat Rev Mol Cell Biol 1 2000 31 39
4. F.M. Goni, and A. Alonso Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids Biochim Biophys Acta 1758 2006 1902 1921
5. F.M. Goni, and A. Alonso Effects of ceramide and other simple sphingolipids on membrane lateral structure Biochim Biophys Acta 1788 2009 169 177
6. A.H. Merrill Jr. Cell regulation by sphingosine and more complex sphingolipids J Bioenerg Biomembr 23 1991 83 104
7. A.H. Merrill Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway J Biol Chem 277 2002 25843 25846
8. A.H. Merrill Jr., and D.D. Jones An update of the enzymology and regulation of sphingomyelin metabolism Biochim Biophys Acta 1044 1990 1 12
9. A.H. Merrill Jr., E.M. Schmelz, D.L. Dillehay, S. Spiegel, J.A. Shayman, and J.J. Schroeder Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology Toxicol Appl Pharmacol 142 1997 208 225
10. R. Kolesnick The therapeutic potential of modulating the ceramide/sphingomyelin pathway J Clin Invest 110 2002 3 8
11. R. Kolesnick, and D.W. Golde The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling Cell 77 1994 325 328
12. R.N. Kolesnick 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells J Biol Chem 262 1987 16759 16762
13. R.N. Kolesnick, and M.R. Hemer Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity J Biol Chem 265 1990 18803 18808
14. T. Wennekes, R.J. van den Berg, R.G. Boot, G.A. van der Marel, H.S. Overkleeft, and J.M. Aerts Glycosphingolipids - nature, function, and pharmacological modulation Angew Chem, Int Ed Engl 48 2009 8848 8869
15. S. Chatterjee, A. Kolmakova, and M. Rajesh Regulation of lactosylceramide synthase (glucosylceramide beta1 → 4 galactosyltransferase); implication as a drug target Curr Drug Targets 9 2008 272 281
16. M. Langeveld, and J.M. Aerts Glycosphingolipids and insulin resistance Prog Lipid Res 48 2009 196 205
17. G.A. Grabowski Treatment perspectives for the lysosomal storage diseases Expert Opin Emerg Drugs 13 2008 197 211
18. A.O. Speak, V. Cerundolo, and F.M. Platt CD1d presentation of glycolipids Immunol Cell Biol 86 2008 588 597
19. A. Gomez-Munoz Ceramide 1-phosphate/ceramide, a switch between life and death Biochim Biophys Acta 1758 2006 2049 2056
20. A. Gomez-Munoz Ceramide-1-phosphate: a novel regulator of cell activation FEBS Lett 562 2004 5 10
21. C.E. Chalfant, and S. Spiegel Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling J Cell Sci 118 2005 4605 4612
22. N.F. Lamour, and C.E. Chalfant Ceramide-1-phosphate: the "missing" Link in eicosanoid biosynthesis and inflammation Mol Interv 5 2005 358 367
23. B.J. Pettus, C.E. Chalfant, and Y.A. Hannun Sphingolipids in inflammation: roles and implications Curr Mol Med 4 2004 405 418
24. Y.A. Hannun Functions of ceramide in coordinating cellular responses to stress Science 274 1996 1855 1859
25. Y.A. Hannun The sphingomyelin cycle and the second messenger function of ceramide J Biol Chem 269 1994 3125 3128
26. Y.A. Hannun, C.R. Loomis, A.H. Merrill Jr., and R.M. Bell Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets J Biol Chem 261 1986 12604 12609
27. Y.A. Hannun, and L.M. Obeid Ceramide: an intracellular signal for apoptosis Trends Biochem Sci 20 1995 73 77
28. Y.A. Hannun, and L.M. Obeid The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind J Biol Chem 277 2002 25847 25850
29. E. Hertervig, A. Nilsson, Y. Cheng, and R.D. Duan Purified intestinal alkaline SMase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells J Cancer Res Clin Oncol 129 2003 577 582
30. R.D. Duan, and A. Nilsson Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development Prog Lipid Res 48 2009 62 72
31. R.S. Hundal, A. Gomez-Munoz, J.Y. Kong, B.S. Salh, A. Marotta, and V. Duronio Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels J Biol Chem 278 2003 24399 24408
32. A. Gomez-Munoz, J. Kong, B. Salh, and U.P. Steinbrecher Sphingosine-1-phosphate inhibits acid SMase and blocks apoptosis in macrophages FEBS Lett 539 2003 56 60
33. A. Gomez-Munoz, J.Y. Kong, B. Salh, and U.P. Steinbrecher Ceramide-1-phosphate blocks apoptosis through inhibition of acid SMase in macrophages J Lipid Res 45 2004 99 105
34. C. Luberto, and Y.A. Hannun Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 273 1998 14550 14559
35. P. Gangoiti, M.H. Granado, L. Arana, A. Ouro, and A. Gomez-Munoz Activation of protein kinase C-alpha is essential for stimulation of cell proliferation by ceramide 1-phosphate FEBS Lett 584 2009 517 524
36. S. Spiegel, D. English, and S. Milstien Sphingosine 1-phosphate signaling: providing cells with a sense of direction Trends Cell Biol 12 2002 236 242
37. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
38. S. Spiegel, and S. Milstien Sphingosine 1-phosphate, a key cell signaling molecule J Biol Chem 277 2002 25851 25854
39. N.C. Hait, C.A. Oskeritzian, S.W. Paugh, S. Milstien, and S. Spiegel Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases Biochim Biophys Acta 1758 2006 2016 2026
40. S. Pyne, S.C. Lee, J. Long, and N.J. Pyne Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease Cell Signal 21 2009 14 21
41. R.H. Kim, K. Takabe, S. Milstien, and S. Spiegel Export and functions of sphingosine-1-phosphate Biochim Biophys Acta 1791 2009 692 696
42. H. Liu, M. Sugiura, V.E. Nava, L.C. Edsall, K. Kono, and S. Poulton Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform J Biol Chem 275 2000 19513 19520
43. T.A. Taha, Y.A. Hannun, and L.M. Obeid Sphingosine kinase: biochemical and cellular regulation and role in disease J Biochem Mol Biol 39 2006 113 131
44. T. Levade, S. Malagarie-Cazenave, V. Gouaze, B. Segui, C. Tardy, and S. Betito Ceramide in apoptosis: a revisited role Neurochem Res 27 2002 601 607
45. L. Riboni, R. Campanella, R. Bassi, R. Villani, S.M. Gaini, F. Martinelli-Boneschi, P. Viani, and G. Tettamanti Ceramide levels are inversely associated with malignant progression of human glial tumors Glia 39 2002 105 113
46. D.A. Litvak, A.J. Bilchik, and M.C. Cabot Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy J Gastrointest Surg 7 2003 140 148
47. U.P. Steinbrecher, A. Gomez-Munoz, and V. Duronio Acid SMase in macrophage apoptosis Curr Opin Lipidol 15 2004 531 537
48. M.S. Song, and E.I. Posse de Chaves Inhibition of rat sympathetic neuron apoptosis by ceramide. Role of p75NTR in ceramide generation Neuropharmacology 45 2003 1130 1150
49. G. Plummer, K.R. Perreault, C.F. Holmes, and E.I. Posse De Chaves Activation of serine/threonine protein phosphatase-1 is required for ceramide-induced survival of sympathetic neurons Biochem J 385 2005 685 693
50. F.M. Goni, and A. Alonso SMases: enzymology and membrane activity FEBS Lett 531 2002 38 46
51. A.E. Cremesti, F.M. Goni, and R. Kolesnick Role of SMase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 531 2002 47 53
52. R.N. Kolesnick, F.M. Goni, and A. Alonso Compartmentalization of ceramide signaling: physical foundations and biological effects J Cell Physiol 184 2000 285 300
53. K. Hanada, K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, and M. Fukasawa Molecular machinery for non-vesicular trafficking of ceramide Nature 426 2003 803 809
54. A. Huwiler, D. Fabbro, and J. Pfeilschifter Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells Biochemistry 37 1998 14556 14562
55. T.E. Fox, K.L. Houck, S.M. O'Neill, M. Nagarajan, T.C. Stover, and P.T. Pomianowski Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains J Biol Chem 282 2007 12450 12457
56. N.A. Bourbon, J. Yun, D. Berkey, Y. Wang, and M. Kester Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions Am J Physiol Cell Physiol 280 2001 C1403 C1411
57. A.I. Ibitayo, J. Sladick, S. Tuteja, O. Louis-Jacques, H. Yamada, and G. Groblewski HSP27 in signal transduction and association with contractile proteins in smooth muscle cells Am J Physiol 277 1999 G445 G454
58. H. Sawai, T. Okazaki, Y. Takeda, M. Tashima, H. Sawada, and M. Okuma J Biol Chem 272 1997 2452 2458
59. M. Sumitomo, M. Ohba, J. Asakuma, T. Asano, T. Kuroki, and T. Asano Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells J Clin Invest 109 2002 827 836
60. T. Kajimoto, Y. Shirai, N. Sakai, T. Yamamoto, H. Matsuzaki, and U. Kikkawa Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cdelta in the Golgi complex J Biol Chem 279 2004 12668 12676
61. A. Gomez-Munoz Modulation of cell signalling by ceramides Biochim Biophys Acta 1391 1998 92 109
62. A. Gomez-Munoz, A. Martin, L. O'Brien, and D.N. Brindley Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts J Biol Chem 269 1994 8937 8943
63. A. Gomez-Munoz, D.W. Waggoner, L. O'Brien, and D.N. Brindley Interaction of ceramides, sphingosine,and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity J Biol Chem 270 1995 26318 26325
64. A. Gomez-Munoz, J.S. Martens, and U.P. Steinbrecher Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages Arterioscler Thromb Vasc Biol 20 2000 135 143
65. A. Gomez-Munoz, L. O'Brien, R. Hundal, and U.P. Steinbrecher Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages J Lipid Res 40 1999 988 993
66. A. Gomez-Munoz, L. O'Brien, and U.P. Steinbrecher The platelet-activating factor receptor antagonist L-659,989 inhibits phospholipase D activity Biochim Biophys Acta 1438 1999 247 252
67. M. Rabano, A. Pena, L. Brizuela, J.M. Macarulla, A. Gomez-Munoz, and M. Trueba Angiotensin II-stimulated cortisol secretion is mediated by phospholipase D Mol Cell Endocrinol 222 2004 9 20
68. M. Rabano, A. Pena, L. Brizuela, A. Marino, J.M. Macarulla, and M. Trueba Sphingosine-1-phosphate stimulates cortisol secretion FEBS Lett 535 2003 101 105
69. M.E. Venable, and L.M. Obeid Phospholipase D in cellular senescence Biochim Biophys Acta 1439 1999 291 298
70. E. Perez-Andres, M. Fernandez-Rodriguez, M. Gonzalez, A. Zubiaga, A. Vallejo, and I. Garcia Activation of phospholipase D-2 by P2X(7) agonists in rat submandibular gland acini J Lipid Res 43 2002 1244 1255
71. A. Abousalham, C. Liossis, L. O'Brien, and D.N. Brindley Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA J Biol Chem 272 1997 1069 1075
72. M.E. Venable, A. Bielawska, and L.M. Obeid Ceramide inhibits phospholipase D in a cell-free system J Biol Chem 271 1996 24800 24805
73. M.M. Kockx, G.R. De Meyer, N. Buyssens, M.W. Knaapen, H. Bult, and A.G. Herman Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal Circ Res 83 1998 378 387
74. S. Katsuda, M.D. Coltrera, R. Ross, and A.M. Gown Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults Am J Pathol 142 1993 1787 1793
75. R. Dhami, X. He, R.E. Gordon, and E.H. Schuchman Analysis of the lung pathology and alveolar macrophage function in the acid SMase - deficient mouse model of Niemann-Pick disease Lab Invest 81 2001 987 999
76. C. Mao, and L.M. Obeid Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate Biochim Biophys Acta 1781 2008 424 434
77. C. Mao, R. Xu, Z.M. Szulc, A. Bielawska, S.H. Galadari, and L.M. Obeid Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide J Biol Chem 276 2001 26577 26588
78. M. Nikolova-Karakashian, and A.H. Merrill Jr. Ceramidases Meth Enzymol 311 2000 194 201
79. E. Yavin, and S. Gatt Enzymatic hydrolysis of sphingolipids. 8. Further purification and properties of rat brain ceramidase Biochemistry 8 1969 1692 1698
80. T. Babia, J.W. Kok, C. Hulstaert, H. de Weerd, and D. Hoekstra Differential metabolism and trafficking of sphingolipids in differentiated versus undifferentiated HT29 cells Int J Cancer 54 1993 839 845
81. M. Nikolova-Karakashian, E.T. Morgan, C. Alexander, D.C. Liotta, and A.H. Merrill Jr. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11 J Biol Chem 272 1997 18718 18724
82. M. Tani, K. Kita, H. Komori, T. Nakagawa, and M. Ito Enzymatic synthesis of omega-amino-ceramide: preparation of a sensitive fluorescent substrate for ceramidase Anal Biochem 263 1998 183 188
83. M. Tani, N. Okino, S. Mitsutake, and M. Ito Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-ceramide J Biochem 125 1999 746 749
84. N. Filippa, C.L. Sable, C. Filloux, B. Hemmings, and E. Van Obberghen Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase Mol Cell Biol 19 1999 4989 5000
85. N. Shtraizent, E. Eliyahu, J.H. Park, X. He, R. Shalgi, and E.H. Schuchman Autoproteolytic cleavage and activation of human acid ceramidase J Biol Chem 283 2008 11253 11259
86. W.F. Nieuwenhuizen, S. van Leeuwen, F. Gotz, and M.R. Egmond Synthesis of a novel fluorescent ceramide analogue and its use in the characterization of recombinant ceramidase from Pseudomonas aeruginosa PA01 Chem Phys Lipids 114 2002 181 191
87. W.F. Nieuwenhuizen, S. van Leeuwen, R.W. Jack, M.R. Egmond, and F. Gotz Molecular cloning and characterization of the alkaline ceramidase from Pseudomonas aeruginosa PA01 Protein Expr Purif 30 2003 94 104
88. C. Bedia, J. Casas, V. Garcia, T. Levade, and G. Fabrias Synthesis of a novel ceramide analogue and its use in a high-throughput fluorogenic assay for ceramidases Chembiochem 8 2007 642 648
89. C. Bedia, D. Canals, X. Matabosch, Y. Harrak, J. Casas, and A. Llebaria Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides Chem Phys Lipids 156 2008 33 40
90. X. He, A. Dagan, S. Gatt, and E.H. Schuchman Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3- dicarboxyaldehyde derivatization after hydrolysis with ceramidase Anal Biochem 340 2005 113 122
91. J. Bar, T. Linke, K. Ferlinz, U. Neumann, E.H. Schuchman, and K. Sandhoff Molecular analysis of acid ceramidase deficiency in patients with Farber disease Hum Mutat 17 2001 199 209
92. K. Ehlert, M. Frosch, N. Fehse, A. Zander, J. Roth, and J. Vormoor Farber disease: clinical presentation, pathogenesis and a new approach to treatment Pediatr Rheumatol Online J 5 2007 15
93. S. Ramsubir, T. Nonaka, C.B. Girbes, S. Carpentier, T. Levade, and J.A. Medin In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease Mol Genet Metab 95 2008 133 141
94. J.A. Medin, T. Takenaka, S. Carpentier, V. Garcia, J.P. Basile, and B. Segui Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells Hum Gene Ther 10 1999 1321 1329
95. J. Arikawa, M. Ishibashi, M. Kawashima, Y. Takagi, Y. Ichikawa, and G. Imokawa Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus J Invest Dermatol 119 2002 433 439
96. K. Higuchi, J. Hara, R. Okamoto, M. Kawashima, and G. Imokawa The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide Biochem J 350 Pt 3 2000 747 756
97. E. Houben, J.P. Hachem, K. De Paepe, and V. Rogiers Epidermal ceramidase activity regulates epidermal desquamation via stratum corneum acidification Skin Pharmacol Physiol 21 2008 111 118
98. E. Houben, W.M. Holleran, T. Yaginuma, C. Mao, L.M. Obeid, and V. Rogiers Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis J Lipid Res 47 2006 1063 1070
99. B.J. Pettus, K. Kitatani, C.E. Chalfant, T.A. Taha, T. Kawamori, and J. Bielawski The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate Mol Pharmacol 68 2005 330 335
100. Y. Ohnishi, N. Okino, M. Ito, and S. Imayama Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis Clin Diagn Lab Immunol 6 1999 101 104
101. M. Serova, A. Ghoul, K.A. Benhadji, S. Faivre, C. Le Tourneau, and E. Cvitkovic Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells Mol Cancer Ther 7 2008 915 922
102. Y.J. Jiang, Y. Uchida, B. Lu, P. Kim, C. Mao, and M. Akiyama Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytes J Biol Chem 284 2009 18942 18952
103. X. He, Y. Huang, B. Li, C.X. Gong, and E.H. Schuchman Deregulation of sphingolipid metabolism in Alzheimer's disease Neurobiol Aging 31 2008 398 408
104. Y. Huang, H. Tanimukai, F. Liu, K. Iqbal, I. Grundke-Iqbal, and C.X. Gong Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain Eur J Neurosci 20 2004 3489 3497
105. H. Grassme, K.A. Becker, Y. Zhang, and E. Gulbins Ceramide in bacterial infections and cystic fibrosis Biol Chem 389 2008 1371 1379
106. V. Teichgraber, M. Ulrich, N. Endlich, J. Riethmuller, B. Wilker, and C.C. De Oliveira-Munding Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis Nat Med 14 2008 382 391
107. J. Riethmuller, J. Anthonysamy, E. Serra, M. Schwab, G. Doring, and E. Gulbins Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis Cell Physiol Biochem 24 2009 65 72
108. M. El Alwani, J. Usta, G. Nemer, M. El Sabban, M. Nasser, and H. Bitar Regulation of the sphingolipid signaling pathways in the growing and hypoxic rat heart Prostaglandins Other Lipid Mediat 78 2005 249 263
109. D.X. Zhang, R.M. Fryer, A.K. Hsu, A.P. Zou, G.J. Gross, and W.B. Campbell Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats Basic Res Cardiol 96 2001 267 274
110. N. Auge, M. Nikolova-Karakashian, S. Carpentier, S. Parthasarathy, A. Negre-Salvayre, and R. Salvayre Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of SMase, ceramidase, and sphingosine kinase J Biol Chem 274 1999 21533 21538
111. K. Geoffroy, L. Troncy, N. Wiernsperger, M. Lagarde, and S. El Bawab Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels FEBS Lett 579 2005 1249 1254
112. K. Geoffroy, N. Wiernsperger, M. Lagarde, and S. El Bawab Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids J Biol Chem 279 2004 34343 34352
113. R.A. Zager, D.S. Conrad, and K. Burkhart Ceramide accumulation during oxidant renal tubular injury: mechanisms and potential consequences J Am Soc Nephrol 9 1998 1670 1680
114. C. Partovian, R. Ju, Z.W. Zhuang, K.A. Martin, and M. Simons Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells Mol Cell 32 2008 140 149
115. M. Straczkowski, I. Kowalska, M. Baranowski, A. Nikolajuk, E. Otziomek, and P. Zabielski Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes Diabetologia 50 2007 2366 2373
116. F. Samad, K.D. Hester, G. Yang, Y.A. Hannun, and J. Bielawski Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk Diabetes 55 2006 2579 2587
117. A. Blachnio-Zabielska, P. Zabielski, M. Baranowski, and J. Gorski Effects of streptozotocin-induced diabetes and elevation of plasma FFA on ceramide metabolism in rat skeletal muscle Horm Metab Res 2009
118. J.A. Chavez, W.L. Holland, J. Bar, K. Sandhoff, and S.A. Summers Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling J Biol Chem 280 2005 20148 20153
119. R. Franzen, D. Fabbro, A. Aschrafi, J. Pfeilschifter, and A. Huwiler Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase C J Biol Chem 277 2002 46184 46190
120. R. Franzen, J. Pfeilschifter, and A. Huwiler Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures FEBS Lett 532 2002 441 444
121. K. Pahan, F.G. Sheikh, M. Khan, A.M. Namboodiri, and I. Singh SMase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes J Biol Chem 273 1998 2591 2600
122. 2+ transients and contraction of adult rat cardiomyocytes Am J Physiol Cell Physiol 282 2002 C1339 1347
123. Y. Hatano, H. Terashi, S. Arakawa, and K. Katagiri Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis J Invest Dermatol 124 2005 786 792
124. Z. Chen, J. Sun, A. Pradines, G. Favre, J. Adnane, and S.M. Sebti Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice J Biol Chem 275 2000 17974 17978
125. H. Oral, G.W. Dorn 2nd, and D.L. Mann Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte J Biol Chem 272 1997 4836 4842
126. Y. Fang, M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen Phosphatidic acid-mediated mitogenic activation of mTOR signaling Science 294 2001 1942 1945
127. M. Kaszkin, A. Huwiler, K. Scholz, H. van den Bosch, and J. Pfeilschifter Negative regulation of interleukin-1beta-activated neutral SMase by protein kinase C in rat mesangial cells FEBS Lett 440 1998 163 166
128. R. Franzen, A. Pautz, L. Brautigam, G. Geisslinger, J. Pfeilschifter, and A. Huwiler Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells J Biol Chem 276 2001 35382 35389
129. Y.H. Zeidan, R.W. Jenkins, J.B. Korman, X. Liu, L.M. Obeid, and J.S. Norris Molecular targeting of acid ceramidase: implications to cancer therapy Curr Drug Targets 9 2008 653 661
130. Y. Osawa, H. Uchinami, J. Bielawski, R.F. Schwabe, Y.A. Hannun, and D.A. Brenner Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha J Biol Chem 280 2005 27879 27887
131. A. Strelow, K. Bernardo, S. Adam-Klages, T. Linke, K. Sandhoff, and M. Kronke Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death J Exp Med 192 2000 601 612
132. W.J. De Vito, K. Xhaja, and S. Stone Prenatal alcohol exposure increases TNFalpha-induced cytotoxicity in primary astrocytes Alcohol 21 2000 63 71
133. E. Coroneos, M. Martinez, S. McKenna, and M. Kester Differential regulation of SMase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation J Biol Chem 270 1995 23305 23309
134. S.G. Payne, D.N. Brindley, and L.J. Guilbert Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts J Cell Physiol 180 1999 263 270
135. W. Sun, W. Hu, R. Xu, J. Jin, Z.M. Szulc, and G. Zhang Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion FASEB J 23 2009 656 666
136. J.M. Adams 2nd, T. Pratipanawatr, R. Berria, E. Wang, R.A. DeFronzo, and M.C. Sullards Ceramide content is increased in skeletal muscle from obese insulin-resistant humans Diabetes 53 2004 25 31
137. M. Korzeniowski, A.B. Shakor, A. Makowska, A. Drzewiecka, A. Bielawska, and K. Kwiatkowska Fc gamma RII activation induces cell surface ceramide production which participates in the assembly of the receptor signaling complex Cell Physiol Biochem 20 2007 347 356
138. T. Ozbay, A.H. Merrill Jr., and M.B. Sewer ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism Endocr Res 30 2004 787 794
139. N. Lucki, and M.B. Sewer The cAMP-responsive element binding protein (CREB) regulates the expression of acid ceramidase (ASAH1) in H295R human adrenocortical cells Biochim Biophys Acta 1791 2009 706 713
140. A.N. Urs, E. Dammer, and M.B. Sewer Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1 Endocrinology 147 2006 5249 5258
141. A.E. Mahdy, J.C. Cheng, J. Li, S. Elojeimy, W.D. Meacham, and L.S. Turner Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer Mol Ther 17 2009 430 438
142. N. Okino, and M. Ito Ceramidase enhances phospholipase C-induced hemolysis by Pseudomonas aeruginosa J Biol Chem 282 2007 6021 6030
143. X. Liu, S. Elojeimy, L.S. Turner, A.E. Mahdy, Y.H. Zeidan, and A. Bielawska Acid ceramidase inhibition: a novel target for cancer therapy Front Biosci 13 2008 2293 2298
144. J.H. Park, and E.H. Schuchman Acid ceramidase and human disease Biochim Biophys Acta 1758 2006 2133 2138
145. S. Elojeimy, X. Liu, J.C. McKillop, A.M. El-Zawahry, D.H. Holman, and J.Y. Cheng Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy Mol Ther 15 2007 1259 1263
146. R.S. Seelan, C. Qian, A. Yokomizo, D.G. Bostwick, D.I. Smith, and W. Liu Human acid ceramidase is overexpressed but not mutated in prostate cancer Genes Chromosomes Cancer 29 2000 137 146
147. D.K. Perry, J. Carton, A.K. Shah, F. Meredith, D.J. Uhlinger, and Y.A. Hannun Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis J Biol Chem 275 2000 9078 9084
148. E. Ruckhaberle, A. Rody, K. Engels, R. Gaetje, G. von Minckwitz, and S. Schiffmann Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer Breast Cancer Res Treat 112 2008 41 52
149. E. Ruckhaberle, U. Holtrich, K. Engels, L. Hanker, R. Gatje, and D. Metzler Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer Climacteric 2009 1 12
150. A.F. Saad, W.D. Meacham, A. Bai, V. Anelli, S. Elojeimy, and A.E. Mahdy The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy Cancer Biol Ther 6 2007 1455 1460
151. L. Thon, S. Mathieu, D. Kabelitz, and D. Adam The murine TRAIL receptor signals caspase-independent cell death through ceramide Exp Cell Res 312 2006 3808 3821
152. M. Eto, J. Bennouna, O.C. Hunter, M.T. Lotze, and A.A. Amoscato Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells Int J Urol 13 2006 148 156
153. W. Zheng, J. Kollmeyer, H. Symolon, A. Momin, E. Munter, and E. Wang Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy Biochim Biophys Acta 1758 2006 1864 1884
154. B.X. Wu, Y.H. Zeidan, and Y.A. Hannun Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation Biochim Biophys Acta 1791 2009 730 739
155. E. Houben, Y. Uchida, W.F. Nieuwenhuizen, K. De Paepe, T. Vanhaecke, and W.M. Holleran Kinetic characteristics of acidic and alkaline ceramidase in human epidermis Skin Pharmacol Physiol 20 2007 187 194
156. M. Selzner, A. Bielawska, M.A. Morse, H.A. Rudiger, D. Sindram, and Y.A. Hannun Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer Cancer Res 61 2001 1233 1240
157. M. Raisova, G. Goltz, M. Bektas, A. Bielawska, C. Riebeling, and A.M. Hossini Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes FEBS Lett 516 2002 47 52
158. L. Samsel, G. Zaidel, H.M. Drumgoole, D. Jelovac, C. Drachenberg, and J.G. Rhee The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts Prostate 58 2004 382 393
159. Z.M. Szulc, N. Mayroo, A. Bai, J. Bielawski, X. Liu, and J.S. Norris Novel analogs of d-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents Bioorg Med Chem 2007
160. D.S. Wijesinghe, P. Subramanian, N.F. Lamour, L.B. Gentile, M.H. Granado, and Z. Szulc The chain length specificity for the activation of group IV cytosolic phospholipase A2 by ceramide-1-phosphate. Use of the dodecane delivery system for determining lipid-specific effects J Lipid Res 2008
161. D.H. Holman, L.S. Turner, A. El-Zawahry, S. Elojeimy, X. Liu, and J. Bielawski Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells Cancer Chemother Pharmacol 61 2008 231 242
162. T. Granot, D. Milhas, S. Carpentier, A. Dagan, B. Segui, and S. Gatt Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs Leukemia 20 2006 392 399
163. S. Elojeimy, D.H. Holman, X. Liu, A. El-Zawahry, M. Villani, and J.C. Cheng New insights on the use of desipramine as an inhibitor for acid ceramidase FEBS Lett 580 2006 4751 4756
164. A. Bai, Z.M. Szulc, J. Bielawski, N. Mayroo, X. Liu, and J. Norris Synthesis and bioevaluation of omega-N-amino analogs of B13 Bioorg Med Chem 17 2009 1840 1848
165. A. Bielawska, J. Bielawski, Z.M. Szulc, N. Mayroo, X. Liu, and A. Bai Novel analogs of d-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids Bioorg Med Chem 16 2007 1032 1045
166. H.K. Lim, Y.A. Choi, W. Park, T. Lee, S.H. Ryu, and S.Y. Kim Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway J Biol Chem 278 2003 45117 45127
167. 2+ signaling Cell Signal 21 2009 440 447
168. Z. Nahas, Y. Jiang, Y.H. Zeidan, A. Bielawska, Z. Szulc, and L. Devane Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats Behav Brain Res 197 2009 41 44
169. H. Inoue, T. Someno, T. Kato, H. Kumagai, M. Kawada, and D. Ikeda Ceramidastin, a novel bacterial ceramidase inhibitor, produced by Penicillium sp. Mer-f17067 J Antibiot (Tokyo) 2009
170. E.R. Smith, P.L. Jones, J.M. Boss, and A.H. Merrill Jr. Changing J774A. 1 cells to new medium perturbs multiple signaling pathways including the modulation of protein kinase C by endogenous sphingoid bases J Biol Chem 272 1997 5640 5646
171. A. Gomez-Munoz, E.H. Hamza, and D.N. Brindley Effects of sphingosine, albumin and unsaturated fatty acids on the activation and translocation of phosphatidate phosphohydrolases in rat hepatocytes Biochim Biophys Acta 1127 1992 49 56
172. Z. Jamal, A. Martin, A. Gomez-Munoz, and D.N. Brindley Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol J Biol Chem 266 1991 2988 2996
173. V. Natarajan, H.N. Jayaram, W.M. Scribner, and J.G. Garcia Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate Am J Respir Cell Mol Biol 11 1994 221 229
174. F. Sakane, K. Yamada, and H. Kanoh Different effects of sphingosine R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol FEBS Lett 255 1989 409 413
175. K. Yamada, F. Sakane, S. Imai, and H. Takemura Sphingosine activates cellular diacylglycerol kinase in intact Jurkat cells, a human T-cell line Biochim Biophys Acta 1169 1993 217 224
176. N.N. Desai, H. Zhang, A. Olivera, M.E. Mattie, and S. Spiegel Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation J Biol Chem 267 1992 23122 23128
177. K. Watterson, H. Sankala, S. Milstien, and S. Spiegel Pleiotropic actions of sphingosine-1-phosphate Prog Lipid Res 42 2003 344 357
178. M. Garcia-Pacios, M.I. Collado, J.V. Busto, J. Sot, A. Alonso, and J.L. Arrondo Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments Biophys J 97 2009 1398 1407
179. M. Sugiura, K. Kono, H. Liu, T. Shimizugawa, H. Minekura, and S. Spiegel Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization J Biol Chem 277 2002 23294 23300
180. A. Kihara, Y. Anada, and Y. Igarashi Mouse sphingosine kinase isoforms SPHK1a and SPHK1b differ in enzymatic traits including stability, localization, modification and oligomerization J Biol Chem 281 2006 4532 4539
181. K. Venkataraman, S. Thangada, J. Michaud, M.L. Oo, Y. Ai, and Y.M. Lee Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient Biochem J 397 2006 461 471
182. K. Hogenauer, A. Billich, C. Pally, M. Streiff, T. Wagner, and K. Welzenbach Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues ChemMedChem 2008 1027 1029
183. T. Baumruker, A. Billich, and V. Brinkmann FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis Expert Opin Invest Drugs 16 2007 283 289
184. S. Lee, and K.R. Lynch Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA) Biochem J 391 2005 317 323
185. M. Maceyka, H. Sankala, N.C. Hait, H. Le Stunff, H. Liu, and R. Toman Sphk1 and Sphk2: sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J Biol Chem 280 2005 37118 37129
186. B.M. Buehrer, and R.M. Bell Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways J Biol Chem 267 1992 3154 3159
187. Y. Igarashi, S. Hakomori, T. Toyokuni, B. Dean, S. Fujita, and M. Sugimoto Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities Biochemistry 28 1989 6796 6800
188. A.H. Merrill Jr., S. Nimkar, D. Menaldino, Y.A. Hannun, C. Loomis, and R.M. Bell Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds Biochemistry 28 1989 3138 3145
189. O. Cuvillier, G. Pirianov, B. Kleuser, P.G. Vanek, O.A. Coso, and S. Gutkind Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate Nature 381 1996 800 803
190. Y. Yatomi, F. Ruan, T. Megidish, T. Toyokuni, S. Hakomori, and Y. Igarashi N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets Biochemistry 35 1996 626 633
191. A. Delgado, J. Casas, A. Llebaria, J.L. Abad, and G. Fabrias Inhibitors of sphingolipid metabolism enzymes Biochim Biophys Acta-Biomembranes 1758 2006 1957 1977
192. K.J. French, R.S. Schrecengost, B.D. Lee, Y. Zhuang, S.N. Smith, and J.L. Eberly Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Res 63 2003 5962 5969
193. J.W. Kim, Y. Inagaki, S. Mitsutake, N. Maezawa, S. Katsumura, and Y.W. Ryu Suppression of mast cell degranulation by a novel ceramide kinase inhibitor the F-12509A olefin isomer K1 Biochim Biophys Acta 1738 2005 82 90
194. J.W. Kim, Y.W. Kim, Y. Inagaki, Y.A. Hwang, S. Mitsutake, and Y.W. Ryu Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases Bioorg Med Chem 13 2005 3475 3485
195. Y. Xiang, G. Asmussen, M. Booker, B. Hirth, J.L. Kane Jr., and J. Liao Discovery of novel sphingosine kinase 1 inhibitors Bioorg Med Chem Lett 19 2009 6119 6121
196. L. Wong, S.S. Tan, Y. Lam, and A.J. Melendez Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases J Med Chem 52 2009 3618 3626
197. French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther 2010 [in press].
198. Maines LW, Fitzpatrick LR, Green CL, Zhuang Y, Smith CD. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease, Inflammopharmacology 2010 [in press].
199. E.R. Sharlow, S. Leimgruber, A. Yellow-Duke, R. Barrett, Q.J. Wang, and J.S. Lazo Development, validation and implementation of immobilized metal affinity for phosphochemicals (IMAP)-based high-throughput screening assays for low-molecular-weight compound libraries Nat Protoc 3 2008 1350 1363
200. M. Habig, A. Blechschmidt, S. Dressler, B. Hess, V. Patel, and A. Billich Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists J Biomol Screen 14 2009 679 689
201. B. Visentin, J.A. Vekich, B.J. Sibbald, A.L. Cavalli, K.M. Moreno, and R.G. Matteo Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion and angiogenesis in multiple tumor lineages Cancer Cell 9 2006 225 238
202. N. O'Brien, S.T. Jones, D.G. Williams, H.B. Cunningham, K. Moreno, and B. Visentin Production and characterization of monoclonal anti-sphingosine-1- phosphate antibodies J Lipid Res 50 2009 2245 2257
203. J.M. Wojciak, N. Zhu, K.T. Schuerenberg, K. Moreno, W.S. Shestowsky, and M. Hiraiwa The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen Proc Natl Acad Sci USA 106 2009 17717 17722
204. S. Yoshida, A. Fujisawa-Sehara, T. Taki, K. Arai, and Y. Nabeshima Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts J Cell Biol 132 1996 181 193
205. O. Cuvillier Sphingosine kinase-1 - a potential therapeutic target in cancer Anticancer Drugs 18 2007 105 110
206. M. Minhajuddin, K.M. Bijli, F. Fazal, A. Sassano, K.I. Nakayama, and N. Hay Protein kinase Cdelta and PI3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappa B activation and ICAM-1 expression in endothelial cells J Biol Chem 284 2009 4052 4061
207. Y. Akao, Y. Banno, Y. Nakagawa, N. Hasegawa, T.J. Kim, and T. Murate High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation Biochem Biophys Res Commun 342 2006 1284 1290
208. P. Xia, J.R. Gamble, L. Wang, S.M. Pitson, P.A. Moretti, and B.W. Wattenberg An oncogenic role of sphingosine kinase Curr Biol 10 2000 1527 1530
209. S. Sarkar, M. Maceyka, N.C. Hait, S.W. Paugh, H. Sankala, and S. Milstien Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells FEBS Lett 579 2005 5313 5317
210. E. Bonhoure, D. Pchejetski, N. Aouali, H. Morjani, T. Levade, and T. Kohama Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1 Leukemia 20 2006 95 102
211. D. Pchejetski, M. Golzio, E. Bonhoure, C. Calvet, N. Doumerc, and V. Garcia Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models Cancer Res 65 2005 11667 11675
212. D. Pchejetski, N. Doumerc, M. Golzio, M. Naymark, J. Teissie, and T. Kohama Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models Mol. Cancer Ther 7 2008 1836 1845
213. K.J. French, J.J. Upson, S.N. Keller, Y. Zhuang, J.K. Yun, and C.D. Smith Antitumor activity of sphingosine kinase inhibitors J Pharmacol Exp Ther 318 2006 596 603
214. C. Ricci, F. Onida, F. Servida, F. Radaelli, G. Saporiti, and K. Todoerti In vitro anti-leukaemia activity of sphingosine kinase inhibitor Br J Haematol 144 2009 350 357
215. A.E. Alewijnse, and S.L. Peters Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol 585 2008 292 302
216. W. Siess Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate Biochim Biophys Acta 1582 2002 204 215
217. T. Machida, Y. Hamaya, S. Izumi, Y. Hamaya, K. Iizuka, and Y. Igarashi Sphingosine 1-phosphate inhibits nitric oxide production induced by interleukin-1beta in rat vascular smooth muscle cells J Pharmacol Exp Ther 325 2008 200 209
218. L. Brizuela, M. Rabano, A. Pena, P. Gangoiti, J.M. Macarulla, and M. Trueba Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion J Lipid Res 47 2006 1238 1249
219. L. Brizuela, M. Rabano, P. Gangoiti, N. Narbona, J.M. Macarulla, and M. Trueba Sphingosine-1-phosphate stimulates aldosterone secretion through a mechanism involving the PI3K/PKB and MEK/ERK 1/2 pathways J Lipid Res 48 2007 2264 2274
220. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
221. G. Daum, A. Grabski, and M.A. Reidy Sphingosine 1-phosphate: a regulator of arterial lesions Arterioscler Thromb Vasc Biol 29 2009 1439 1443
222. A.J. Ammit, A.T. Hastie, L.C. Edsall, R.K. Hoffman, Y. Amrani, and V.P. Krymskaya Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma FASEB J. 15 2001 1212 1214
223. T. Nishiuma, Y. Nishimura, T. Okada, E. Kuramoto, Y. Kotani, and S. Jahangeer Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model Am J Physiol Lung Cell Mol Physiol 294 2008 L1085 1093
224. C. Lee, D.Z. Xu, E. Feketeova, K.B. Kannan, J.K. Yun, and E.A. Deitch Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition J Trauma 57 2004 955 960
225. J. Rivera, R.L. Proia, and A. Olivera The alliance of sphingosine-1-phosphate and its receptors in immunity Nat Rev Immunol 8 2008 753 763
226. E.W. St Clair Novel targeted therapies for autoimmunity Curr Opin Immunol 2009
227. E.J. Goetzl, J.J. Liao, and M.C. Huang Regulation of the roles of sphingosine 1-phosphate and its type 1 G protein-coupled receptor in T cell immunity and autoimmunity Biochim Biophys Acta 1781 2008 503 507
228. M.P. Wymann, and R. Schneiter Lipid signalling in disease Nat Rev Mol Cell Biol 9 2008 162 176
229. J.D. Saba, and T. Hla Point-counterpoint of sphingosine 1-phosphate metabolism Circ Res 94 2004 724 734
230. D.W. Waggoner, A. Gomez-Munoz, J. Dewald, and D.N. Brindley Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide, 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate J Biol Chem 271 1996 16506 16509
231. D.N. Brindley, and D.W. Waggoner Mammalian lipid phosphate phosphohydrolases J Biol Chem 273 1998 24281 24284
232. H. Le Stunff, A. Mikami, P. Giussani, J.P. Hobson, P.S. Jolly, and S. Milstien Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis J Biol Chem 279 2004 34290 34297
233. B. Ogretmen, B.J. Pettus, M.J. Rossi, R. Wood, J. Usta, and Z. Szulc Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide J Biol Chem 277 2002 12960 12969
234. E.I. de Chaves, M. Bussiere, D.E. Vance, R.B. Campenot, and J.E. Vance Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons J Biol Chem 272 1997 3028 3035
235. S.M. Bajjalieh, T.F. Martin, and E. Floor Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles J Biol Chem 264 1989 14354 14360
236. S. Mitsutake, T.J. Kim, Y. Inagaki, M. Kato, T. Yamashita, and Y. Igarashi Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells J Biol Chem 279 2004 17570 17577
237. A. Boath, C. Graf, E. Lidome, T. Ullrich, P. Nussbaumer, and F. Bornancin Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin J Biol Chem 283 2008 8517 8526
238. N.F. Lamour, R.V. Stahelin, D.S. Wijesinghe, M. Maceyka, E. Wang, and J.C. Allegood Ceramide kinase uses ceramide provided by ceramide transport prote, localization to organelles of eicosanoid synthesis J Lipid Res 48 2007 1293 1304
239. T. Baumruker, F. Bornancin, and A. Billich The role of sphingosine and ceramide kinases in inflammatory responses Immunol Lett 96 2005 175 185
240. T.J. Kim, S. Mitsutake, M. Kato, and Y. Igarashi The leucine 10 residue in the pleckstrin homology domain of ceramide kinase is crucial for its catalytic activity FEBS Lett 579 2005 4383 4388
241. T.J. Kim, S. Mitsutake, and Y. Igarashi The interaction between the pleckstrin homology domain of ceramide kinase phosphatidylinositol 4,5-bisphosphate regulates the plasma membrane targeting and ceramide 1-phosphate levels Biochem Biophys Res Commun 342 2006 611 617
242. E. Lidome, C. Graf, M. Jaritz, A. Schanzer, P. Rovina, and R. Nikolay A conserved cysteine motif essential for ceramide kinase function Biochimie 90 2008 1560 1565
243. P. Rovina, A. Schanzer, C. Graf, D. Mechtcheriakova, M. Jaritz, and F. Bornancin Subcellular localization of ceramide kinase and ceramide kinase-like protein requires interplay of their Pleckstrin Homology domain-containing N-terminal regions together with C-terminal domains Biochim Biophys Acta 1791 2009 1023 1030
244. D.S. Wijesinghe, A. Massiello, P. Subramanian, Z. Szulc, A. Bielawska, and C.E. Chalfant Substrate specificity of human ceramide kinase J Lipid Res 46 2005 2706 2716
245. H. Van Overloop, Y. Denizot, M. Baes, and P.P. Van Veldhoven On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase Biol Chem 388 2007 315 324
246. A. Gomez-Munoz, P.A. Duffy, A. Martin, L. O'Brien, H.S. Byun, and R. Bittman Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides Mol Pharmacol 47 1995 833 839
247. B.J. Pettus, A. Bielawska, S. Spiegel, P. Roddy, Y.A. Hannun, and C.E. Chalfant Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release J Biol Chem 278 2003 38206 38213
248. M. Tuson, G. Marfany, and R. Gonzalez-Duarte Mutation of CERKL a novel human ceramide kinase gene causes autosomal recessive retinitis pigmentosa (RP26) Am J Hum Genet 74 2004 128 138
249. C. Graf, B. Zemann, P. Rovina, N. Urtz, A. Schanzer, and R. Reuschel Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice J Immunol 180 2008 3457 3466
250. F. Bornancin, D. Mechtcheriakova, S. Stora, C. Graf, A. Wlachos, and P. Devay Characterization of a ceramide kinase-like protein Biochim Biophys Acta 1687 2005 31 43
251. G. Rile, Y. Yatomi, T. Takafuta, and Y. Ozaki Ceramide 1-phosphate formation in neutrophils Acta Haematol 109 2003 76 83
252. L. Riboni, R. Bassi, V. Anelli, and P. Viani Metabolic formation of ceramide-1-phosphate in cerebellar granule cells: evidence for the phosphorylation of ceramide by different metabolic pathways Neurochem Res 27 2002 711 716
253. P. Gangoiti, M.H. Granado, S.W. Wang, J.Y. Kong, U.P. Steinbrecher, and A. Gomez-Munoz Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways Cell Signal 20 2008 726 736
254. A. Gomez-Munoz, L.M. Frago, L. Alvarez, and I. Varela-Nieto Stimulation of DNA synthesis by natural ceramide 1-phosphate Biochem J 325 Pt 2 1997 435 440
255. B.J. Pettus, A. Bielawska, P. Subramanian, D.S. Wijesinghe, M. Maceyka, C.C. Leslie, and J.H. Evans Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2 J Biol Chem 279 2004 11320 11326
256. S. Gijsbers, G.P. Mannaerts, B. Himpens, and P.P. Van Veldhoven N-acetyl-sphingenine-1-phosphate is a potent calcium mobilizing agent FEBS Lett 453 1999 269 272
257. S. Hogback, P. Leppimaki, B. Rudnas, S. Bjorklund, J.P. Slotte, and K. Tornquist Ceramide 1-phosphate increases intracellular free calcium concentrations in thyroid FRTL-5 cells: evidence for an effect mediated by inositol 1,4,5-trisphosphate and intracellular sphingosine 1-phosphate Biochem J 370 2003 111 119
258. 2+ mobilization in Jurkat T-cells by elevation of Ins(1,4,5)-P3 and activation of a store-operated calcium channel Biochem Biophys Res Commun 336 2005 54 60
259. A. Gomez-Munoz, J.Y. Kong, K. Parhar, S.W. Wang, P. Gangoiti, and M. Gonzalez Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway FEBS Lett 579 2005 3744 3750
260. P. Mitra, M. Maceyka, S.G. Payne, N. Lamour, S. Milstien, and C.E. Chalfant Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells FEBS Lett 581 2007 735 740
261. C. Graf, P. Rovina, L. Tauzin, A. Schanzer, and F. Bornancin Enhanced ceramide-induced apoptosis in ceramide kinase overexpressing cells Biochem Biophys Res Commun 354 2007 309 314
262. E.E. Kooijman, J. Sot, L.R. Montes, A. Alonso, A. Gericke, and B. de Kruijff Membrane organization and ionization behavior of the minor but crucial lipid ceramide-1-phosphate Biophys J 94 2008 4320 4330
263. R. Hurwitz, K. Ferlinz, and K. Sandhoff The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal SMase in human fibroblasts Biol Chem Hoppe Seyler 375 1994 447 450
264. M.H. Granado, P. Gangoiti, A. Ouro, L. Arana, and A. Gomez-Munoz Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages Biochim Biophys Acta 1791 2009 263 272
265. F.D. Testai, M.A. Landek, R. Goswami, M. Ahmed, and G. Dawson Acid SMase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling J Neurochem 89 2004 636 644
266. M.P. Scheid, and J.R. Woodgett Unravelling the activation mechanisms of protein kinase B/Akt FEBS Lett 546 2003 108 112
267. M.P. Scheid, M. Huber, J.E. Damen, M. Hughes, V. Kang, and P. Neilsen Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice J Biol Chem 277 2002 9027 9035
268. C.L. Sable, N. Filippa, B. Hemmings, and E. Van Obberghen cAMP stimulates protein kinase B in a Wortmannin-insensitive manner FEBS Lett 409 1997 253 257
269. K. Van Kolen, K. Gilany, L. Moens, E.L. Esmans, and H. Slegers P2Y12 receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1 Cell Signal 18 2006 1169 1181
270. E. Gulbins, and R. Kolesnick Raft ceramide in molecular medicine Oncogene 22 2003 7070 7077
271. C.N. Serhan, J.Z. Haeggstrom, and C.C. Leslie Lipid mediator networks in cell signaling: update and impact of cytokines FASEB J 10 1996 1147 1158
272. S.K. Manna, and B.B. Aggarwal IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis J Immunol 161 1998 2863 2872
273. R. Newton, L. Hart, K.F. Chung, and P.J. Barnes Ceramide induction of COX-2 and PGE(2) in pulmonary A549 cells does not involve activation of NF-kappaB Biochem Biophys Res Commun 277 2000 675 679
274. M. Hayakawa, S. Jayadev, M. Tsujimoto, Y.A. Hannun, and F. Ito Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2 Biochem Biophys Res Commun 220 1996 681 686
275. E. Masini, L. Giannini, S. Nistri, L. Cinci, R. Mastroianni, and W. Xu Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response airway inflammation J Pharmacol Exp Ther 324 2008 548 557
276. V.V. Prasad, K. Nithipatikom, and D.R. Harder Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytes Neurochem Int 53 2008 220 229
277. R. Goggel, S. Winoto-Morbach, G. Vielhaber, Y. Imai, K. Lindner, and L. Brade PAF-mediated pulmonary edema: a new role for acid SMase and ceramide Nat Med 10 2004 155 160
278. P. Subramanian, R.V. Stahelin, Z. Szulc, A. Bielawska, W. Cho, and C.E. Chalfant Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine J Biol Chem 280 2005 17601 17607
279. D.S. Wijesinghe, N.F. Lamour, A. Gomez-Munoz, and C.E. Chalfant Ceramide kinase and ceramide-1-phosphate Meth Enzymol 434 2007 265 292
280. V. Hinkovska-Galcheva, L.A. Boxer, A. Kindzelskii, M. Hiraoka, A. Abe, and S. Goparju Ceramide 1-phosphate, a mediator of phagocytosis J Biol Chem 280 2005 26612 26621
281. V.T. Hinkovska-Galcheva, L.A. Boxer, P.J. Mansfield, D. Harsh, A. Blackwood, and J.A. Shayman The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion J Biol Chem 273 1998 33203 33209
282. D.J. Rader, and A. Daugherty Translating molecular discoveries into new therapies for atherosclerosis Nature 451 2008 904 913
283. J.J. Hendriks, C.E. Teunissen, H.E. de Vries, and C.D. Dijkstra Macrophages and neurodegeneration Brain Res Brain Res Rev 48 2005 185 195
284. J. Condeelis, and J.W. Pollard Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2006 263 266
285. M.H. Granado, P. Gangoiti, A. Ouro, L. Arana, M. Gonzalez, and M. Trueba Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor Cell Signal 21 2009 405 412
286. R.S. Lankalapalli, A. Ouro, L. Arana, A. Gomez-Munoz, and R. Bittman Caged ceramide 1-phosphate analogues: synthesis and properties J Org Chem 74 2009 8844 8847
287. M. Goldsmith, D. Avni, G. Levy-Rimler, R. Mashiach, O. Ernst, and M. Levi A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophages Immunology 2008
288. H. Kumada, S. Mitsutake, Y. Inagaki, S. Mitsunaga, H. Tsuchikawa, and S. Katsumura Kinetics of the ceramide kinase inhibitor K1, a suppressor of mast-cell activation Biosci Biotechnol Biochem 71 2007 2581 2584
289. C. Graf, M. Klumpp, M. Habig, P. Rovina, A. Billich, and T. Baumruker Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor Mol Pharmacol 74 2008 925 932
290. Y. Lavie, H. Cao, A. Volner, A. Lucci, T.Y. Han, and V. Geffen Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells J Biol Chem 272 1997 1682 1687
291. M.C. Cabot, A.E. Giuliano, A. Volner, and T.Y. Han Tamoxifen retards glycosphingolipid metabolism in human cancer cells FEBS Lett 394 1996 129 131
292. T. Momoi, Y. Ben-Yoseph, and H.L. Nadler Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls Biochem J 205 1982 419 425
293. S. El Bawab, A. Bielawska, and Y.A. Hannun Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain J Biol Chem 274 1999 27948 27955
294. 14C]ceramide synthesis by sphingolipid ceramide N-deacylase: new assay for ceramidase activity detection Anal Biochem 247 1997 52 57
295. K. Bernardo, R. Hurwitz, T. Zenk, R.J. Desnick, K. Ferlinz, and E.H. Schuchman Purification, characterization, and biosynthesis of human acid ceramidase J Biol Chem 270 1995 11098 11102
296. R. Xu, J. Jin, W. Hu, W. Sun, J. Bielawski, and Z. Szulc Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P FASEB J 20 2006 1813 1825
297. K.W. Cho Bioluminescent assay for sphingolipid ceramide N-deacylase using Vibrio harveyi dark mutant M-17 J Microbiol 46 2008 585 589